For example, NGAL is considered an excellent biomarker for the early prediction of CKD32, and Bolignano et al. 33 suggested that NGAL could serve as a biomarker of atherosclerosis or CVD as well as CKD progression. This evidence concerns the gene LCN2 and chronic kidney disease.